Skip to main content
Caplight Logo









RaayonNova

RaayonNova

Private
New York City, New YorkFrontier & Industrial Techhttps://ar-smart-lens.com

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RaayonNova operates in Frontier & Industrial Tech and is based in New York City, New York. It was founded in 2014.

RaayonNova is a medical technology company developing AR and VR-enabled smart contact lens systems with embedded displays for vision correction and enhancement.

Sector

Frontier & Industrial Tech

Verticals

AR/VR Hardware, Medical Devices, Consumer Electronics, AR/VR Experiences

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

RaayonNova Comparables

Compare RaayonNova with similar companies based on industry and business-model similarity.

RaayonNova comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InWith Corporation
79%
Xpanceo
79%
Innovega Inc.
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

RaayonNova Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for RaayonNova. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Alex Ziskis

CTO Co-Founder

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors increased 30% MoM.

  • Jul 25, 2026

    Monthly visitors increased 44% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

RaayonNova Filings

Explore SEC and related filing metadata, where available.

RaayonNova filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about RaayonNova's valuation, stock price, and market status.

Is RaayonNova a public or private company?

RaayonNova is a private company.

What is the current stock price of RaayonNova?

RaayonNova is a private company, so its shares have no public market price. Caplight tracks RaayonNova's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RaayonNova worth (valuation)?

Valuation information for RaayonNova is not publicly available.

Can I buy RaayonNova stock?

RaayonNova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RaayonNova's last funding round?

Funding round information for RaayonNova is not publicly available.

Who are the main investors in RaayonNova?

Investor information for RaayonNova is not publicly disclosed.

Will RaayonNova IPO soon?

No public IPO plans have been announced for RaayonNova.

How can I track RaayonNova secondary market activity?

Caplight tracks bids, offers, and trades in RaayonNova's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range2
Year Founded2014
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?